Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe-/- mice

Author(s):
Bot, I. (0000-0002-1242-1959); Delfos, L.; Hemme, E.; Bernabé Kleijn, M.N.A.; Santbrink, P.J. van; Foks, A.C. (0000-0002-9747-3458); Kovanen, P.T.; Jouppila, A.; Lassila, R.
Published
2024
Publication type
Article / Letter to editor
InflammationHeparin proteoglycansAnimal modelPlaque stability
Date issued
2024-09-06
Language
English
Is part of
Atherosclerosis (2024), 118567
hdl
1887/4104993
doi
10.1016/j.atherosclerosis.2024.118567